Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Eder

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Orbit (Amsterdam, Netherlands)|November 14, 2019
Blue rubber bleb nevus syndrome of the orbit and gastrointestinal tractStephen C Dryden, Adrianna E Eder, Andrew G Meador, et al.
IARC Scientific Publications|January 1, 1994
DNA adducts of allyl compounds, enals and unsaturated ketones. Significance for mutagenicity and carcinogenicityE Eder, D Sebeikat, J P Zugelder, et al.
Cancer Research|October 27, 1998
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptorA Hobisch, I E Eder, T Putz, et al.
The Prostate|October 12, 2000
Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture modelsC Nessler-Menardi, I Jotova, Z Culig, et al.
Journal of Neurological Surgery. Part B, Skull Base|June 30, 2022
Pediatric Orbital Roof Fractures: A Ratio of Orbital Dimensions Correlated to Prevalence of FractureStephen C Dryden, Andrew G Meador, Andrew B Johnston, et al.
Clinical Prostate Cancer|October 4, 2005
Molecular effects of the isoflavonoid genistein in prostate cancerJasmin Bektic, Roman Guggenberger, Iris E Eder, et al.
Molecular Endocrinology (Baltimore, Md.)|October 10, 2015
Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In VivoPhilipp Ofer, Isabel Heidegger, Iris E Eder, et al.
The Prostate|January 27, 2004
Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cellsKarina Pfeil, Iris E Eder, Thomas Putz, et al.
International Journal of Molecular Sciences|September 7, 2016
Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid CultureTheresa Eder, Anja Weber, Hannes Neuwirt, et al.
Cancer Research|January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Orbit (Amsterdam, Netherlands)|November 14, 2019
Blue rubber bleb nevus syndrome of the orbit and gastrointestinal tractStephen C Dryden, Adrianna E Eder, Andrew G Meador, et al.
IARC Scientific Publications|January 1, 1994
DNA adducts of allyl compounds, enals and unsaturated ketones. Significance for mutagenicity and carcinogenicityE Eder, D Sebeikat, J P Zugelder, et al.
Cancer Research|October 27, 1998
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptorA Hobisch, I E Eder, T Putz, et al.
The Prostate|October 12, 2000
Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture modelsC Nessler-Menardi, I Jotova, Z Culig, et al.
Journal of Neurological Surgery. Part B, Skull Base|June 30, 2022
Pediatric Orbital Roof Fractures: A Ratio of Orbital Dimensions Correlated to Prevalence of FractureStephen C Dryden, Andrew G Meador, Andrew B Johnston, et al.
Clinical Prostate Cancer|October 4, 2005
Molecular effects of the isoflavonoid genistein in prostate cancerJasmin Bektic, Roman Guggenberger, Iris E Eder, et al.
Molecular Endocrinology (Baltimore, Md.)|October 10, 2015
Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In VivoPhilipp Ofer, Isabel Heidegger, Iris E Eder, et al.
The Prostate|January 27, 2004
Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cellsKarina Pfeil, Iris E Eder, Thomas Putz, et al.
International Journal of Molecular Sciences|September 7, 2016
Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid CultureTheresa Eder, Anja Weber, Hannes Neuwirt, et al.
Cancer Research|January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.
Pageof 17